Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Research & Development (2016 - 2025)

Fortress Biotech has reported Research & Development over the past 13 years, most recently at -$367000.0 for Q4 2025.

  • Quarterly results put Research & Development at -$367000.0 for Q4 2025, down 103.79% from a year ago — trailing twelve months through Dec 2025 was $11.9 million (down 78.98% YoY), and the annual figure for FY2025 was $11.9 million, down 78.98%.
  • Research & Development for Q4 2025 was -$367000.0 at Fortress Biotech, down from $208000.0 in the prior quarter.
  • Over the last five years, Research & Development for FBIO hit a ceiling of $58.6 million in Q4 2021 and a floor of -$367000.0 in Q4 2025.
  • Median Research & Development over the past 5 years was $22.6 million (2023), compared with a mean of $22.3 million.
  • Biggest five-year swings in Research & Development: soared 7961.6% in 2021 and later plummeted 103.79% in 2025.
  • Fortress Biotech's Research & Development stood at $58.6 million in 2021, then crashed by 40.02% to $35.2 million in 2022, then plummeted by 60.06% to $14.0 million in 2023, then plummeted by 31.02% to $9.7 million in 2024, then plummeted by 103.79% to -$367000.0 in 2025.
  • The last three reported values for Research & Development were -$367000.0 (Q4 2025), $208000.0 (Q3 2025), and $8.1 million (Q2 2025) per Business Quant data.